ConductScience.org, home

Trial · NCT05096403

Outcomes33

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYNumber of Patients Achieving a Response (R) at Week 24Week 24ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYChange From Baseline to Week 24 in Hemoglobin (Hgb) Level-Part A in the Absence of Intercurrent Events (ICEs).Week 24grams per deciliter (g/dL)LEAST_SQUARES_MEAN
SECONDARYNumber of Patients Achieving Transfusion Avoidance From Week 5 to Week 24-Part AWeek 24Number of Patients Achieving Transfusion Avoidance at Week 24ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYChange From Baseline to Week 24 in FACT-An Scale Score (Quality of Life)-Part A in the Absence of Intercurrent Events (ICEs)Week 24Part AUnits on a scaleMEAN
SECONDARYNumber of Packed Red Blood Cell Transfusions Received by Patients From Week 5 to Week 24-Part AWeek 24Number of transfusionsMEAN
SECONDARYChange From Baseline to Week 24 in LDH Levels-Part A in the Absence of Intercurrent Events (ICEs)Week 24U/LMEAN
SECONDARYChange From Baseline to Week 24 in Haptoglobin Levels-Part A in the Absence of Intercurrent Events (ICEs)Week 24g/LMEAN
SECONDARYChange From Baseline to Week 24 in Indirect Bilirubin-Part A in the Absence of Intercurrent Events (ICE)Week 24µmol/LMEAN
SECONDARYChange From Baseline to Week 24 in ARC-Part A in the Absence of Intercurrent Events (ICEs)Week 2410^9 cells/LMEAN
SECONDARYChange From Baseline to Week 24 in D-dimer Levels-Part A in the Absence of Intercurrent Events (ICEsWeek 24µg/L FEUMEAN
SECONDARYNormalization of Markers of Hemolysis (LDH) at Week 24-Part AWeek 24ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNormalization of Markers of Hemolysis (Indirect Bilirubin) at Week 24-Part AWeek 24ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNormalization of Markers of Hemolysis (ARC) at Week 24-Part AWeek 24ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNormalization of Markers of Hemolysis (Haptoglobin) at Week 24-Part AWeek 24ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYCount and Percentage of Patients With a First Normalization From Baseline by Week 24 for Haptoglobin Levels-Part AWeek 24ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYCount and Percentage of Patients With a First Normalization From Baseline by Week 24 for Hemoglobin Levels-Part AWeek 24ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYCount and Percentage of Patients With a First Normalization From Baseline by Week 24 for LDH Levels-Part AWeek 24ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYCount and Percentage of Patients With a First Normalization From Baseline by Week 24 for Indirect Bilirubin Levels-Part AWeek 24ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYCount and Percentage of Patients With a First Normalization From Baseline by Week 24 for ARC Levels-Part AWeek 24ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNumber of Packed Red Blood Cell Units Transfused From Week 5 to Week 24-Part AWeek 5 to Week 24Number of PRBC units transfusedMEAN

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT05096403/outcomes